Drug Eluting Balloon Market

Drug Eluting Balloon Market (Product: Coronary Drug Eluting Balloon, Peripheral Drug Eluting Balloon, and Others; and Technology: Paccocath, FreePac, TransPax, EnduraCoat, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Global Drug Eluting Balloon Market Analysis 2031

  • The industry was valued at US$ 571.1 Mn in 2022
  • It is estimated to grow at a CAGR of 7.1% from 2023 to 2031 and reach US$ 1.0 Bn by the end of 2031

Analyst Viewpoint

Rise in prevalence of vascular diseases and increase in demand for minimally invasive surgeries are accelerating the drug eluting balloon industry growth. People prefer surgeries with less incisions and minimum blood loss due to faster recovery rate and minimum hospitalization period. These surgeries have high accuracy rate, as they are performed with laparoscopic imaging techniques and robotic surgical equipment. Thus, surge in demand for advanced treatments for cardiovascular diseases is boosting drug eluting balloon market dynamics.

High prevalence of peripheral artery disease among the elderly population is driving the demand for drug eluting balloons. Increase in investments in the healthcare sector and availability of reimbursement policies are fueling market progress. Leading market players are launching new products under government guidelines to ensure high accuracy and effectiveness of treatments.

Global Drug Eluting Balloon Market

Market Introduction

Drug Eluting Balloon (DEB) is a type of angioplasty balloon that is coated with anti-proliferative drugs. These drugs are released into the vessel wall while the balloon is inflated, usually at nominal pressure with a specific minimal inflation time. This allows for the rapid delivery of the drug into the vessel wall.

Drug eluting balloon angioplasty is a medical procedure that is used to treat narrowed or blocked arteries. It involves the insertion of a catheter into an artery. The catheter is then used to inflate the balloon and deliver drug to the affected area.

Drug-coated balloon has the potential to prevent cell division, which limits the amount of restenosis or blockage re-growth after treatment.

Lutonix drug coated balloon is a catheter that has paclitaxel applied to the balloon. Drug-eluting balloons are commonly coated with drugs such as paclitaxel, a cytotoxic, and antineoplastic agent.

Increase in Prevalence of Vascular Diseases Driving Drug Eluting Balloon Market Value

Vascular diseases affect blood vessels carrying nutrients and oxygen in the body. These diseases are caused due to plaque, which restricts the blood flow in veins and arteries. Major causes of these diseases are diabetes, blood infections, blood vessel spasms, blood vessel defects, and inflammation of arteries.

Drug eluting balloons are used to open up blocked veins and arteries. Aging population is more prone to vascular diseases. Thus, demand for drug eluting balloons is high in this segment.

Cardiovascular diseases affect blood flow in the body, creating blockages in veins. This may lead to heart attacks. People with obesity, diabetes, high cholesterol, and high blood pressure are more prone to cardiovascular diseases. Drug eluting balloons help reduce the risk of in-stent restenosis and late in-sent thrombosis. Targeted drug delivery in interventional cardiology plays an important role in the treatment of cardiovascular diseases.

Rise in Demand for Minimally Invasive Procedures Fueling Market Expansion

Minimally invasive surgeries are procedures that have less number of incisions and smaller cuts. These procedures help reduce bleeding during surgeries and make them less painful. Minimally invasive surgeries ensure faster recovery rate due to fewer incisions and reduced hospitalization period.

Angioplasty surgeries are minimally invasive techniques that are preferred over open cardiovascular surgeries. Drug eluting stents in targeted drug delivery are used in angioplasty surgeries.

Increase in number of minimally invasive surgeries to treat cardiovascular diseases is bolstering the drug eluting balloon market revenue. Patients choose minimally invasive surgeries, as these often entail advanced laparoscopic procedures that are performed through a single incision.

Minimally invasive surgeries are image-guided and robotic surgeries that have high accuracy and faster recovery. Rise in demand for minimally invasive surgeries is driving the drug eluting balloon market demand.

High Incidence of Peripheral Artery Disease Among Aging Population

Peripheral Artery Disease (PAD) is blockage or narrowing of blood vessels from heart to legs caused by the buildup of fatty plaque in atherosclerosis. Symptoms of PAD include painful cramping in the thighs, calf, and hip muscles; leg weakness or numbness; and coldness in lower legs or feet.

Peripheral drug eluting balloons are used to remove fatty plaque and increase blood circulation in the arteries. The peripheral drug eluting balloons segment is projected to hold leading share due to the increase in prevalence of PAD among people aged above 65. Lack of physical activity is one of the key factors that causes PAD among the aging population.

Regional Outlook

North America is likely to hold the largest drug eluting balloon market share during the forecast period. High diagnosis rates and easy availability of treatments for cardiovascular diseases are driving market statistics in the region.

Presence of developed healthcare infrastructure and rise in funding from government as well as public organizations are augmenting the demand for drug eluting balloons in North America. Availability of reimbursement policies for cardiovascular and chronic diseases is encouraging patients in the region to seek treatments. Furthermore, growth in prevalence of PAD and heart diseases is augmenting the drug eluting balloon market size in North America.

Asia Pacific is expected to register steady market growth in the near future owing to the increase in patient population in the region. Rise in demand for minimally invasive surgeries is steering drug eluting balloon market development in Asia Pacific.

Increase in prevalence of diabetes and obesity is one of the leading causes of cardiovascular diseases among the people in Asia Pacific. This is driving drug eluting balloon market demand in the region.

According to the World Health Organization 2023 report, approximately 77 million people aged above 18 years are suffering from diabetes in India. Around 25 million people are pre-diabetic and more than 50% of the people are unaware of their diabetic status.

Analysis of Key Players in Drug Eluting Balloon Industry

Prominent market participants are implementing various growth strategies such as new product launches and innovation in existing product range. These strategies allow companies to enhance their product portfolio and increase their business reach.

Some of the leading companies operating in the industry are Bayer AG, Medtronic, B. Braun Melsungen AG, Cook Medical, Inc., Boston Scientific Corporation, Becton, Dickson and Company, EuroCor, Terumo Corporation, and Koninklijke Philips N.V.

These players have been summarized in the drug eluting balloon market report based on parameters such as company overview, financial overview, business segments, product portfolio, business strategies, and key developments.

Key Developments

  • On October 2, 2023, Cordis, a global leader in development and manufacture of interventional cardiovascular and endovascular technology, announced the acquisition of MedAlliance, a Switzerland-based developer of drug-eluting balloon technology. The acquisition is likely to improve the company's coronary and peripheral vascular product portfolio.
  • On August 9, 2023, Boston Scientific Corporation, a leading manufacturer of innovative medical solutions, announced it had received the U.S. Food and Drug Administration (FDA) approval for the POLARx Cryoablation System. This is a new system with unique capability of enabling two balloon sizes – 28 and 31mm – in one catheter.

Drug Eluting Balloon Market Snapshot

Attribute Detail
Market Size in 2022 US$ 571.1 Mn
Market Forecast (Value) in 2031 US$ 1.0 Bn
Growth Rate (CAGR) 7.1%
Forecast Period 2023-2031
Historical Data Available for 2017-2021
Quantitative Tons US$ Mn/Bn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy and recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • Product
    • Coronary Drug Eluting Balloon
    • Peripheral Drug Eluting Balloon
    • Others
  • Technology
    • Paccocath
    • FreePac
    • TransPax
    • EnduraCoat
    • Others
  • End-user
    • Hospitals and Ambulatory Surgery Centers
    • Cath Labs
    • Others
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Russia
  • Japan
  • China
  • India
  • Australia & New Zealand
  • Brazil
  • Mexico
  • South Africa
  • GCC countries
  • Israel
Companies Profiled
  • Bayer AG
  • Medtronic
  • B. Braun Melsungen AG
  • Cook Medical, Inc.
  • Boston Scientific Corporation
  • Becton, Dickson and Company
  • EuroCor
  • Terumo Corporation
  • Koninklijke Philips N.V.
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global drug eluting balloon market in 2022?

It was valued at US$ 571.1 Mn in 2022

How is the drug eluting balloon industry expected to grow by 2031?

It is projected to register a CAGR of 7.1% from 2023 to 2031

What are the key factors driving the demand for drug eluting balloons?

Increase in prevalence of vascular diseases and rise in demand for minimally invasive procedures

Which was the most lucrative region for drug eluting balloon in 2022?

North America was the most lucrative region in 2022

Who are the key drug eluting balloon manufacturers?

Bayer AG, Medtronic, B. Braun Melsungen AG, Cook Medical, Inc., Boston Scientific Corporation, Becton, Dickson and Company, EuroCor, Terumo Corporation, Koninklijke Philips N.V, and others

    1. Executive Summary

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Drug Eluting Balloon Market

    4. Market Overview

        4.1. Market Segmentation

            4.1.1. Segment Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Drug Eluting Balloon Market Analysis and Forecast, 2023-2031

    5. Key Insights

        5.1. Pipeline Analysis

        5.2. COVID-19 Pandemic Impact on Industry

    6. Drug Eluting Balloon Market Analysis and Forecast, by Product

        6.1. Introduction and Definitions

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Product, 2023-2031

            6.3.1. Coronary Drug Eluting Balloon

            6.3.2. Peripheral Drug Eluting Balloon

            6.3.3. Others

        6.4. Market Attractiveness, by Product

    7. Drug Eluting Balloon Market Analysis and Forecast, by Technology

        7.1. Introduction and Definitions

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by Technology, 2023-2031

            7.3.1. Paccocath

            7.3.2. FreePac

            7.3.3. TransPax

            7.3.4. EnduraCoat

            7.3.5. Others

        7.4. Market Attractiveness, by Technology

    8. Global Drug Eluting Balloon Market Analysis and Forecast, by End-user

        8.1. Introduction and Definitions

        8.2. Key Findings/Developments

        8.3. Market Value Forecast, by End-user, 2023-2031

            8.3.1. Hospitals and Ambulatory Surgery Centers

            8.3.2. Cath Labs

            8.3.3. Others

        8.4. Market Attractiveness, by End-user

    9. Global Drug Eluting Balloon Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Market Value Forecast, by Region, 2023-2031

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Market Attractiveness, by Region

    10. North America Drug Eluting Balloon Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast, by Product, 2023-2031

            10.2.1. Coronary Drug Eluting Balloon

            10.2.2. Peripheral Drug Eluting Balloon

            10.2.3. Others

        10.3. Market Attractiveness, by Product

        10.4. Market Value Forecast, by Technology, 2023-2031

            10.4.1. Paccocath

            10.4.2. FreePac

            10.4.3. TransPax

            10.4.4. EnduraCoat

            10.4.5. Others

        10.5. Market Attractiveness, by Technology

        10.6. Market Value Forecast, by End-user, 2023-2031

            10.6.1. Hospitals and Ambulatory Surgery Centers

            10.6.2. Cath Labs

            10.6.3. Others

        10.7. Market Attractiveness, by End-user

        10.8. Market Value Forecast, by Country, 2023-2031

            10.8.1. U.S.

            10.8.2. Canada

        10.9. Market Attractiveness Analysis

            10.9.1. By Product

            10.9.2. By Technology

            10.9.3. By End-user

            10.9.4. By Country

    11. Europe Drug Eluting Balloon Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Product, 2023-2031

            11.2.1. Coronary Drug Eluting Balloon

            11.2.2. Peripheral Drug Eluting Balloon

            11.2.3. Others

        11.3. Market Attractiveness, by Product

        11.4. Market Value Forecast, by Technology, 2023-2031

            11.4.1. Paccocath

            11.4.2. FreePac

            11.4.3. TransPax

            11.4.4. EnduraCoat

            11.4.5. Others

        11.5. Market Attractiveness, by Technology

        11.6. Market Value Forecast, by End-user, 2023-2031

            11.6.1. Hospitals and Ambulatory Surgery Centers

            11.6.2. Cath Labs

            11.6.3. Others

        11.7. Market Attractiveness, by End-user

        11.8. Market Value Forecast, by Country/Sub-region, 2023-2031

            11.8.1. Germany

            11.8.2. U.K.

            11.8.3. France

            11.8.4. Italy

            11.8.5. Spain

            11.8.6. Rest of Europe

        11.9. Market Attractiveness Analysis

            11.9.1. By Product

            11.9.2. By Technology

            11.9.3. By End-user

            11.9.4. By Country/Sub-region

    12. Asia Pacific Drug Eluting Balloon Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Product, 2023-2031

            12.2.1. Coronary Drug Eluting Balloon

            12.2.2. Peripheral Drug Eluting Balloon

            12.2.3. Others

        12.3. Market Attractiveness, by Product

        12.4. Market Value Forecast, by Technology, 2023-2031

            12.4.1. Paccocath

            12.4.2. FreePac

            12.4.3. TransPax

            12.4.4. EnduraCoat

            12.4.5. Others

        12.5. Market Attractiveness, by Technology

        12.6. Market Value Forecast, by End-user, 2023-2031

            12.6.1. Hospitals and Ambulatory Surgery Centers

            12.6.2. Cath Labs

            12.6.3. Others

        12.7. Market Attractiveness, by End-user

        12.8. Market Value Forecast, by Country/Sub-region, 2023-2031

            12.8.1. China

            12.8.2. Japan

            12.8.3. India

            12.8.4. Australia & New Zealand

            12.8.5. Rest of Asia Pacific

        12.9. Market Attractiveness Analysis

            12.9.1. By Product

            12.9.2. By Technology

            12.9.3. By End-user

            12.9.4. By Country/Sub-region

    13. Latin America Drug Eluting Balloon Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Product, 2023-2031

            13.2.1. Coronary Drug Eluting Balloon

            13.2.2. Peripheral Drug Eluting Balloon

            13.2.3. Others

        13.3. Market Attractiveness, by Product

        13.4. Market Value Forecast, by Technology, 2023-2031

            13.4.1. Paccocath

            13.4.2. FreePac

            13.4.3. TransPax

            13.4.4. EnduraCoat

            13.4.5. Others

        13.5. Market Attractiveness, by Technology

        13.6. Market Value Forecast, by End-user, 2023-2031

            13.6.1. Hospitals and Ambulatory Surgery Centers

            13.6.2. Cath Labs

            13.6.3. Others

        13.7. Market Attractiveness, by End-user

        13.8. Market Value Forecast, by Country/Sub-region, 2023-2031

            13.8.1. Brazil

            13.8.2. Mexico

            13.8.3. Rest of Latin America

        13.9. Market Attractiveness Analysis

            13.9.1. By Product

            13.9.2. By Technology

            13.9.3. By End-user

            13.9.4. By Country/Sub-region

    14. Middle East & Africa Drug Eluting Balloon Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Product, 2023-2031

            14.2.1. Coronary Drug Eluting Balloon

            14.2.2. Peripheral Drug Eluting Balloon

            14.2.3. Others

        14.3. Market Attractiveness, by Product

        14.4. Market Value Forecast, by Technology, 2023-2031

            14.4.1. Paccocath

            14.4.2. FreePac

            14.4.3. TransPax

            14.4.4. EnduraCoat

            14.4.5. Others

        14.5. Market Attractiveness, by Technology

        14.6. Market Value Forecast, by End-user, 2023-2031

            14.6.1. Hospitals and Ambulatory Surgery Centers

            14.6.2. Cath Labs

            14.6.3. Others

        14.7. Market Attractiveness, by End-user

        14.8. Market Value Forecast, by Country/Sub-region, 2023-2031

            14.8.1. GCC Countries

            14.8.2. South Africa

            14.8.3. Rest of Middle East & Africa

        14.9. Market Attractiveness Analysis

            14.9.1. By Product

            14.9.2. By Technology

            14.9.3. By End-user

            14.9.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player - Competition Matrix (By Tier and Size of Companies)

        15.2. Market Share Analysis, by Company (2022)

        15.3. Company Profiles

            15.3.1. Bayer AG

                15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.1.2. Product Portfolio

                15.3.1.3. Financial Overview

                15.3.1.4. SWOT Analysis

                15.3.1.5. Strategic Overview

            15.3.2. Medtronic

                15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.2.2. Product Portfolio

                15.3.2.3. Financial Overview

                15.3.2.4. SWOT Analysis

                15.3.2.5. Strategic Overview

            15.3.3. B. Braun Melsungen AG

                15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.3.2. Product Portfolio

                15.3.3.3. Financial Overview

                15.3.3.4. SWOT Analysis

                15.3.3.5. Strategic Overview

            15.3.4. Cook Medical, Inc.

                15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.4.2. Product Portfolio

                15.3.4.3. Financial Overview

                15.3.4.4. SWOT Analysis

                15.3.4.5. Strategic Overview

            15.3.5. Boston Scientific Corporation

                15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.5.2. Product Portfolio

                15.3.5.3. Financial Overview

                15.3.5.4. SWOT Analysis

                15.3.5.5. Strategic Overview

            15.3.6. Becton, Dickson and Company

                15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.6.2. Product Portfolio

                15.3.6.3. Financial Overview

                15.3.6.4. SWOT Analysis

                15.3.6.5. Strategic Overview

            15.3.7. EuroCor

                15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.7.2. Product Portfolio

                15.3.7.3. Financial Overview

                15.3.7.4. SWOT Analysis

                15.3.7.5. Strategic Overview

            15.3.8. Terumo Corporation

                15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.8.2. Product Portfolio

                15.3.8.3. Financial Overview

                15.3.8.4. SWOT Analysis

                15.3.8.5. Strategic Overview

            15.3.9. Koninklijke Philips N.V.

                15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.9.2. Product Portfolio

                15.3.9.3. Financial Overview

                15.3.9.4. SWOT Analysis

                15.3.9.5. Strategic Overview

    List of Tables

    Table 01: Global Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Product, 2023-2031

    Table 02: Global Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Technology, 2023-2031

    Table 03: Global Drug Eluting Balloon Market Value (US$ Mn) Forecast, by End-user, 2023-2031

    Table 04: Global Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Region, 2023-2031

    Table 05: North America Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Country, 2023-2031

    Table 06: North America Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Product, 2023-2031

    Table 07: North America Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Technology, 2023-2031

    Table 08: North America Drug Eluting Balloon Market Value (US$ Mn) Forecast, by End-user, 2023-2031

    Table 09: Europe Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031

    Table 10: Europe Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Product, 2023-2031

    Table 11: Europe Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Technology, 2023-2031

    Table 12: Europe Drug Eluting Balloon Market Value (US$ Mn) Forecast, by End-user 2023-2031

    Table 13: Asia Pacific Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031

    Table 14: Asia Pacific Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Product, 2023-2031

    Table 15: Asia Pacific Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Technology, 2023-2031

    Table 16: Asia Pacific Drug Eluting Balloon Market Value (US$ Mn) Forecast, by End-user, 2023-2031

    Table 17: Latin America Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031

    Table 18: Latin America Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Product, 2023-2031

    Table 19: Latin America Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Technology, 2023-2031

    Table 20: Latin America Drug Eluting Balloon Market Value (US$ Mn) Forecast, by End-user 2023-2031

    Table 21: Middle East & Africa Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031

    Table 22: Middle East & Africa Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Product, 2023-2031

    Table 23: Middle East & Africa Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Technology, 2023-2031

    Table 24: Middle East & Africa Drug Eluting Balloon Market Value (US$ Mn) Forecast, by End-user 2023-2031

    List of Figures

    Figure 01: Global Drug Eluting Balloon Market Value (US$ Mn) Forecast, 2023-2031

    Figure 02: Global Drug Eluting Balloon Market Value Share, by Product, 2022

    Figure 03: Global Drug Eluting Balloon Market Value Share, by Technology, 2022

    Figure 04: Global Drug Eluting Balloon Market Value Share, by End-user, 2022

    Figure 05: Global Drug Eluting Balloon Market Value Share Analysis, by Product, 2022 and 2031

    Figure 06: Global Drug Eluting Balloon Market Attractiveness Analysis, by Product, 2023-2031

    Figure 07: Global Drug Eluting Balloon Market Value Share Analysis, by Technology, 2022 and 2031

    Figure 08: Global Drug Eluting Balloon Market Attractiveness Analysis, by Technology, 2023-2031

    Figure 09: Global Drug Eluting Balloon Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 10: Global Drug Eluting Balloon Market Attractiveness Analysis, by End-user 2023-2031

    Figure 11: Global Drug Eluting Balloon Market Value Share Analysis, by Region, 2022 and 2031

    Figure 12: Global Drug Eluting Balloon Market Attractiveness Analysis, by Region, 2023-2031

    Figure 13: North America Drug Eluting Balloon Market Value (US$ Mn) Forecast, 2023-2031

    Figure 14: North America Drug Eluting Balloon Market Value Share Analysis, by Country, 2022 and 2031

    Figure 15: North America Drug Eluting Balloon Market Attractiveness Analysis, by Country, 2023-2031

    Figure 16: North America Drug Eluting Balloon Market Value Share Analysis, by Product, 2022 and 2031

    Figure 17: North America Drug Eluting Balloon Market Attractiveness Analysis, by Product, 2023-2031

    Figure 18: North America Drug Eluting Balloon Market Value Share Analysis, by Technology, 2022 and 2031

    Figure 19: North America Drug Eluting Balloon Market Attractiveness Analysis, by Technology, 2023-2031

    Figure 20: North America Drug Eluting Balloon Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 21: North America Drug Eluting Balloon Market Attractiveness Analysis, by End-user 2023-2031

    Figure 22: Europe Drug Eluting Balloon Market Value (US$ Mn) Forecast, 2022-2031

    Figure 23: Europe Drug Eluting Balloon Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 24: Europe Drug Eluting Balloon Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 25: Europe Drug Eluting Balloon Market Value Share Analysis, by Product, 2022 and 2031

    Figure 26: Europe America Drug Eluting Balloon Market Attractiveness Analysis, by Product, 2023-2031

    Figure 27: Europe Drug Eluting Balloon Market Value Share Analysis, by Technology, 2022 and 2031

    Figure 28: Europe Drug Eluting Balloon Market Attractiveness Analysis, by Technology, 2023-2031

    Figure 29: Europe Drug Eluting Balloon Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 30: Europe Drug Eluting Balloon Market Attractiveness Analysis, by End-user 2023-2031

    Figure 31: Asia Pacific Drug Eluting Balloon Market Value (US$ Mn) Forecast, 2023-2031

    Figure 32: Asia Pacific Drug Eluting Balloon Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 33: Asia Pacific Drug Eluting Balloon Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 34: Asia Pacific Drug Eluting Balloon Market Value Share Analysis, by Product, 2022 and 2031

    Figure 35: Asia Pacific America Drug Eluting Balloon Market Attractiveness Analysis, by Product, 2023-2031

    Figure 36: Asia Pacific Drug Eluting Balloon Market Value Share Analysis, by Technology, 2022 and 2031

    Figure 37: Asia Pacific Drug Eluting Balloon Market Attractiveness Analysis, by Technology, 2023-2031

    Figure 38: Asia Pacific Drug Eluting Balloon Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 39: Asia Pacific Drug Eluting Balloon Market Attractiveness Analysis, by End-user 2023-2031

    Figure 40: Latin America Drug Eluting Balloon Market Value (US$ Mn) Forecast, 2022-2031

    Figure 41: Latin America Drug Eluting Balloon Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 42: Latin America Drug Eluting Balloon Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 43: Latin America Drug Eluting Balloon Market Value Share Analysis, by Product, 2022 and 2031

    Figure 44: Latin America Drug Eluting Balloon Market Attractiveness Analysis, by Product, 2023-2031

    Figure 45: Latin America Drug Eluting Balloon Market Value Share Analysis, by Technology, 2022 and 2031

    Figure 46: Latin America Drug Eluting Balloon Market Attractiveness Analysis, by Technology, 2023-2031

    Figure 47: Latin America Drug Eluting Balloon Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 48: Latin America Drug Eluting Balloon Market Attractiveness Analysis, by End-user, 2023-2031

    Figure 49: Middle East & Africa Drug Eluting Balloon Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 50: Middle East & Africa Drug Eluting Balloon Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 51: Middle East & Africa America Drug Eluting Balloon Market Value Share Analysis, by Product, 2022-2031

    Figure 52: Middle East & Africa America Drug Eluting Balloon Market Attractiveness Analysis, by Product, 2023-2031

    Figure 53: Middle East & Africa Drug Eluting Balloon Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 54: Middle East & Africa Drug Eluting Balloon Market Attractiveness Analysis, by End-user 2023-2031

    Figure 55: Global Drug Eluting Balloon Market Share Analysis, by Company (2022)

Copyright © Transparency Market Research, Inc. All Rights reserved